trending Market Intelligence /marketintelligence/en/news-insights/trending/d8l8qvfetiu1iqawl6qdxw2 content esgSubNav
In This List

Cocrystal Pharma stocks uplisted on Nasdaq

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cocrystal Pharma stocks uplisted on Nasdaq

Cocrystal Pharma Inc. said its shares were approved for listing on the Nasdaq Capital Market.

The company's common stock commenced trading on the market March 12 under the symbol COCP.

Tucker, Ga.-based Cocrystal is a clinical stage biotechnology company developing treatments for hepatitis, influenza and noroviruses.

Nasdaq Capital Markets are focused on helping companies raise capital.